Benefit of Vasodilating β‐Blockers in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention: Nationwide Multicenter Cohort Study

Benefit of Vasodilating β‐Blockers in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention: Nationwide Multicenter Cohort Study

BackgroundAlthough current guidelines recommend β‐blocker after acute myocardial infarction (MI), the role of β‐blocker has not been well investigated in the modern reperfusion era. In particular, the benefit of vasodilating β‐blocker over conventional β‐blocker is still unexplored. Methods and Resu...

Full description

Bibliographic Details
Main Authors: Jaehoon Chung, Jung‐Kyu Han, Young Jo Kim, Chong Jin Kim, Youngkeun Ahn, Myeong Chan Cho, Shung Chull Chae, In‐Ho Chae, Jei Keon Chae, In‐Whan Seong, Han‐Mo Yang, Kyung‐Woo Park, Hyun‐Jae Kang, Bon‐Kwon Koo, Myung Ho Jeong, Hyo‐Soo Kim
Format: Article
Language:English
Published: Wiley 2017-10-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
acute myocardial infarction
beta‐blocker
cohort study
prognosis
propensity score
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.117.007063

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.117.007063

Similar Items